India's drugs regulator on Sunday gave final approval for the emergency use of a two-dose coronavirus vaccine, COVISHIELD, developed by AstraZeneca and Oxford University. The regulator did not discuss the recommended intervals between shots.
The Central Licensing Authority on Saturday granted permission to Hyderabad-based Bharat Biotech to manufacture Covaxin for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency .
By Krishna N. Das NEW DELHI (Reuters) - India on Sunday granted emergency approval to Bharat Biotech's COVAXIN but faced questions after taking the st.